https://thelifesciencefeed.com/articles/salivary-galectin-9-elevated-in-primary-sjgrens-lacks-disease-activity-correlation The Life Science Feed en 2026-06-04 Salivary Galectin-9 Elevated in Primary Sjögren's, Lacks Disease Activity Correlation https://thelifesciencefeed.com/articles/egpa-early-recognition-targeted-intervention-improve-outcomes The Life Science Feed en 2026-06-04 EGPA: Early Recognition & Targeted Intervention Improve Outcomes https://thelifesciencefeed.com/articles/b-cell-dysregulation-targeted-upstream-in-primary-sjgren-disease The Life Science Feed en 2026-06-04 B-Cell Dysregulation Targeted Upstream in Primary Sjögren Disease https://thelifesciencefeed.com/articles/xlh-management-rheumatology-must-adapt-at-eular-2026 The Life Science Feed en 2026-06-04 XLH Management: Rheumatology Must Adapt at EULAR 2026 https://thelifesciencefeed.com/articles/ra-patients-face-elevated-fracture-risk-eular-2026-highlights The Life Science Feed en 2026-06-04 RA Patients Face Elevated Fracture Risk: EULAR 2026 Highlights https://thelifesciencefeed.com/articles/early-intervention-sle-ln-reduces-long-term-damage The Life Science Feed en 2026-06-04 Early Intervention in SLE/LN Reduces Long-Term Damage https://thelifesciencefeed.com/articles/tlr7-8-inhibition-lupus-eular-2026 The Life Science Feed en 2026-06-04 TLR7/8 Inhibition Offers New Lupus Perspective at EULAR 2026 https://thelifesciencefeed.com/articles/early-axspa-diagnosis-case-based-discussion-eular-2026 The Life Science Feed en 2026-06-04 Early AxSpA Diagnosis: Case-Based Discussion at EULAR 2026 https://thelifesciencefeed.com/articles/cd19-b-cell-targeting-igg4-rd-eular-2026 The Life Science Feed en 2026-06-04 CD19+ B-Cell Targeting Shows Efficacy in IgG4-RD Management https://thelifesciencefeed.com/articles/systemic-sclerosis-eular-2026-highlights-diagnosis-prognosis The Life Science Feed en 2026-06-04 Systemic Sclerosis: EULAR 2026 Highlights Diagnosis, Prognosis https://thelifesciencefeed.com/articles/ra-treatment-optimisation-applying-two-decades-of-progress The Life Science Feed en 2026-06-03 RA Treatment Optimisation: Applying Two Decades of Progress https://thelifesciencefeed.com/articles/eular-2026-polymyalgia-rheumatica-guidelines-rwe The Life Science Feed en 2026-06-03 EULAR 2026: Polymyalgia Rheumatica Guidelines Incorporate RWE https://thelifesciencefeed.com/articles/rapid-sle-control-prevents-organ-damage-eular-2026-focus The Life Science Feed en 2026-06-03 Rapid SLE Control Prevents Organ Damage: EULAR 2026 Focus https://thelifesciencefeed.com/articles/spa-remission-clinical-symptoms-vs-subclinical-inflammation-eular-2026 The Life Science Feed en 2026-06-03 SpA Remission: Clinical Symptoms vs. Subclinical Inflammation at EULAR 2026 https://thelifesciencefeed.com/articles/obesity-management-improves-psoriatic-disease-outcomes The Life Science Feed en 2026-06-03 Obesity Management Improves Psoriatic Disease Outcomes https://thelifesciencefeed.com/articles/sle-pathophysiology-advances-eular-2026-precision-care The Life Science Feed en 2026-06-03 SLE Pathophysiology Advances Inform Future Precision Care at EULAR 2026 https://thelifesciencefeed.com/articles/optimising-psa-axspa-treatment-eular-2026-early-intervention The Life Science Feed en 2026-06-03 Optimising PsA and axSpA Treatment: EULAR 2026 Focuses on Early Intervention https://thelifesciencefeed.com/articles/anca-vasculitis-evolving-strategies-remission-relapse-prevention The Life Science Feed en 2026-06-03 ANCA Vasculitis: Evolving Strategies Target Remission & Relapse Prevention https://thelifesciencefeed.com/articles/car-t-cell-therapy-autoimmune-eular-2026 The Life Science Feed en 2026-06-03 CAR T Cell Therapy Shows Efficacy in Autoimmune Diseases at EULAR 2026 https://thelifesciencefeed.com/articles/lupus-management-progress-persistent-challenges-eular-2026 The Life Science Feed en 2026-06-03 Lupus Management: Progress and Persistent Challenges at EULAR 2026 https://thelifesciencefeed.com/articles/autoantibodies-hidden-drivers-autoimmune-rheumatic-diseases The Life Science Feed en 2026-06-03 Autoantibodies: Hidden Drivers of Autoimmune Rheumatic Diseases https://thelifesciencefeed.com/articles/vexas-syndrome-expert-consensus-multidisciplinary-care-eular-2026 The Life Science Feed en 2026-06-03 VEXAS Syndrome: Expert Consensus on Multidisciplinary Care at EULAR 2026 https://thelifesciencefeed.com/articles/sjogrens-disease-targeting-underlying-activity-beyond-symptoms The Life Science Feed en 2026-06-03 Sjögren’s Disease: Targeting Underlying Activity Beyond Symptoms https://thelifesciencefeed.com/articles/eular-2026-methotrexate-remains-cornerstone-ra-first-line The Life Science Feed en 2026-06-03 EULAR 2026: Methotrexate Remains Cornerstone in RA First-Line https://thelifesciencefeed.com/articles/car-t-cell-therapy-sle-ssc-immune-reset The Life Science Feed en 2026-06-03 CAR T Cell Therapy Shows Promise in SLE and SSc Immune Reset https://thelifesciencefeed.com/articles/multidisciplinary-approach-improves-autoimmune-ild-management The Life Science Feed en 2026-06-03 Multidisciplinary Approach Improves Autoimmune ILD Management